Vascular Adaptations to Single-Sprint Training

NCT05727332 | Completed

• 1 other identifier: U54GM115428
• Study Type: interventional
• Target: 46
• Locations: 1 country
• Sites: 1

Brief Summary

The long-term objective of this research line is to identify and implement an effective and feasible intervention capable of preventing and/or reducing the burden of cardiometabolic and obesity-related diseases that affect Mississippians and others. The pursuit of this long-term objective will begin with achieving the specific aims proposed in this pilot project, which are to determine the effect of single sprint training for improving (1) systemic macro-vascular function, (2) local and systemic micro-vascular function, and (3) cardiorespiratory fitness. These aims will be achieved using a randomized controlled trial whereby 40 males and females will be randomized into an intervention group (n=20) or time-matched negative control group (n=20). The intervention group will perform a single maximal effort sprint on a cycle ergometer for twenty seconds 3 days/week for 4 weeks and the control group will be asked to maintain pre-intervention habits/behavior over 4 weeks. All outcome measures are non-invasive, and will be assessed pre-, mid-, and post-intervention, with the exception of cardiorespiratory fitness, which will be measured pre- and post-. To achieve aim 1, brachial artery flow-mediated dilation via ultrasonography and systolic and diastolic blood pressure via automated oscillometry will be measured on the arm. To achieve aim 2, post-occlusive reactive hyperemia via near-infrared spectroscopy and reactive hyperemia via ultrasound will be measured in the arm and leg, respectively. To achieve aim 3, pulmonary gas exchange will be measured during a graded exercise test on a cycle ergometer. All outcomes will be compared across time between conditions and sex with a three-way Bayesian Repeated Measures ANOVA using pre-values as covariates and an uninformed prior. 95% credible intervals will also be calculated to power future investigations using this intervention. If the intervention is found effective, future studies will be conducted to determine the efficacy of the intervention in larger groups and more clinical populations, and to determine the mechanisms mediating the adaptations. If ineffective, the knowledge gained will be used to develop future interventions.

Conditions

Cardiovascular System

Keywords

Vascular; Cardiorespiratory Fitness

Outcome Measures

Primary Outcomes (2)

• Change from baseline systemic macrovascular function at 2 weeks and 4 weeks

  Systemic macrovascular changes will be quantified by measuring 1) brachial artery flow-mediated dilation via vascular ultrasound, and 2) resting brachial blood pressure via a standard automated blood pressure cuff.

  week 0, week 2, and week 4

• Change from baseline local and systemic microvascular function at 2 weeks and 4 weeks

  Systemic changes in microvascular endothelial function will be quantified by using the post-occlusive reactive hyperemia technique in the arm. Local microvascular function will be measured using the passive leg movement technique for reactive hyperemia and post-occlusive reactive hyperemia in the leg.

  week 0, week 2, and week 4

Secondary Outcomes (1)

• Change from baseline maximal oxygen consumption at 2 weeks and 4 weeks

  week 0, week 2, and week 4

Study Arms (2)

Intervention

EXPERIMENTAL

The intervention group will perform a single maximal effort sprint on a cycle ergometer for twenty seconds 3 days/week for 4 weeks.

Behavioral: Single-Sprint Training

Time-Matched Control

NO INTERVENTION

The control group will be asked to maintain pre-intervention habits/behavior over 4 weeks.

Interventions

Single-Sprint Training BEHAVIORAL

A single maximal effort sprint on a cycle ergometer for twenty seconds 3 days/week for 4 weeks

Intervention

Eligibility Criteria

• Age: 18 Years - 35 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Age 18-35 years
• Untrained (no regular exercise engagement for the previous 6 months)
• Healthy enough to begin exercise (assessed via Physical Activity Readiness Questionnaire)

You may not qualify if:

• Illness/injury preventing cycling exercise
• Prescribed medication to control heart rate
• Prescribed medication to control blood pressure
• Use of nicotine within the previous 6 months

Sponsors & Collaborators

• University of Mississippi, Oxford: lead

Study Sites (1)

University of Mississippi

University, Mississippi, 38677, United States

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Model Details: Intervention group and negative control group

Study Record Dates

• First Submitted: January 26, 2023
• First Posted: February 14, 2023
• Study Start: June 5, 2023
• Primary Completion: July 31, 2024
• Study Completion: December 5, 2024
• Last Updated: June 26, 2025

Record last verified: 2025-06

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)